COVID-19: Are We Facing Secondary Pellagra Which Cannot Simply Be Cured by Vitamin B3?

Novak Kujundzic, Renata

Novak Kujundzic, Renata.

Novak Kujundzic R; Laboratory for Epigenomics, Division of Molecular Medicine, Ruder Boskovic Institute, 10000 Zagreb, Croatia.

Int J Mol Sci ; 23(8)2022 Apr 13.

Article en En | MEDLINE | ID: mdl-35457123

Asunto(s)

COVID-19; Niacina; Pelagra; Humanos; NAD/metabolismo; Niacina/farmacología; Niacinamida/metabolismo; Pelagra/tratamiento farmacológico; Pelagra/etiología; SARS-CoV-2

Palabras clave

NAD+ salvage pathway; aldehyde oxidase; diabetes; inflammaging; nicotinamide N-methyltransferase; nicotinamide adenine dinucleotide; obesity; oxytocin; smell; taste

Texto completo

Imprimir

XML

PubMed Links

Search on Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Pelagra / COVID-19 / Niacina Tipo de estudio: Etiology_studies Límite: Humans Idioma: En Año: 2022 Tipo del documento: Article

Texto completo

Imprimir

XML

PubMed Links

Search on Google